Stephen Dale, Chief Medical Officer at Kura Oncology, Inc. (KURA), sold 16,808 shares at $17.80 ($335K) on 2024-01-29, disclosed to the SEC on 2024-01-31.
Open-market sale of $335k KURA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.80 | 2,758 | $49K | 14.6% |
| 2 | $17.80 | 4,400 | $78K | 23.4% |
| 3 | $21.55 | 4,825 | $104K | 31.0% |
| 4 | $21.55 | 4,825 | $104K | 31.0% |
| Total | $19.95 avg | 16,808 | $335K | 100% |